Edition:
United States

Stryker Corp (SYK.N)

SYK.N on New York Stock Exchange

151.34USD
14 Dec 2017
Change (% chg)

$-1.97 (-1.28%)
Prev Close
$153.31
Open
$153.21
Day's High
$153.65
Day's Low
$151.23
Volume
429,034
Avg. Vol
350,609
52-wk High
$160.60
52-wk Low
$116.30

Chart for

About

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company's segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes... (more)

Overall

Beta: 0.80
Market Cap(Mil.): $57,374.37
Shares Outstanding(Mil.): 374.24
Dividend: 0.47
Yield (%): 1.23

Financials

  Industry Sector
P/E (TTM): -- 57.04 15.47
EPS (TTM): -- -- --
ROI: -- 13.33 33.71
ROE: -- 19.92 16.38

BRIEF-Stryker Announces Howard Cox Jr Will Retire From Board

* STRYKER ANNOUNCES MR. HOWARD COX JR WILL RETIRE FROM BOARD OF DIRECTORS

Dec 12 2017

Stryker beefs up ENT business with $662 million Entellus buy

Medical device maker Stryker Corp said on Thursday it would buy Entellus Medical Inc for $662 million, adding heft to its ear, nose and throat (ENT) business.

Dec 07 2017

UPDATE 1-Stryker beefs up ENT business with $662 mln Entellus buy

Dec 7 Medical device maker Stryker Corp said on Thursday it would buy Entellus Medical Inc for $662 million, adding heft to its ear, nose and throat (ENT) business.

Dec 07 2017

Stryker to buy Entellus Medical for $662 mln

Dec 7 Medical device maker Stryker Corp said on Thursday it would buy medical technology company Entellus Medical Inc in a deal valued at about $662 million, adding heft to its ENT business.

Dec 07 2017

BRIEF-Stryker to buy Entellus Medical for $24.00/share in cash

* ENTELLUS MEDICAL ANNOUNCES DEFINITIVE AGREEMENT TO BE ACQUIRED BY STRYKER CORPORATION FOR A PURCHASE PRICE OF $24.00 PER SHARE IN CASH

Dec 07 2017

BRIEF-Stryker declares $0.47 per share quarterly dividend

* STRYKER INCREASES DIVIDEND 11%, DECLARING A $0.47 PER SHARE QUARTERLY DIVIDEND Source text for Eikon: Further company coverage:

Dec 06 2017

BRIEF-Stryker receives U.S. FDA HDE approval for the Neuroform Atlas stent system to treat wide neck aneurysms

* Stryker receives U.S. FDA HDE approval for the Neuroform Atlas™ stent system to treat wide neck aneurysms

Nov 09 2017

BRIEF-Stryker Corp reports Q3 earnings per share $1.14

* Q3 earnings per share view $1.50 -- Thomson Reuters I/B/E/S

Oct 26 2017

BRIEF-Stryker to acquire Vexim

* Stryker Corp - ‍Stryker paid EUR 20.00 per share and EUR 3.91 per BSAAR warrant for deal​

Oct 24 2017

BRIEF-Stryker receives FDA clearance for Cementless Mako Total Knee with Triathlon® Tritanium®

* Stryker receives FDA clearance for Cementless Mako Total Knee With Triathlon® Tritanium® Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Oct 16 2017

Earnings vs. Estimates